TRANSCAN Call for Research Projects

Contact at the FNR: Frank Glod, PhD

Under the umbrella of the ERA-NET on Translational Cancer Research (TRANSCAN) , a joint transnational call is launched on the topic "Validation of Biomarkers for Personalised Cancer Medicine"

The following funding organisations in fifteen countries from the European Research Area have agreed to fund the joint call for multinational research projects in this area.

• Austrian Science Fund (FWF), Austria
• Research Foundation Flanders (FWO), Belgium
• National Cancer Institute (INCa), France
• Federal Ministry of Education and Research (BMBF), Germany
• General Secretariat for Research and Technology, Ministry of Education, Life Long Learning and Religious Affairs (GSRT), Greece
• Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel
• Ministry of Health (MoH), Italy
• Latvian Academy of Science (LAS), Latvia
• National Research Fund (FNR), Luxembourg
• National Centre for Research and Development (NCBiR), Poland
• Institute of Oncology (IOB), Romania
• Slovak Academy of Sciences (SAS), Slovakia
• Ministry of Higher Education, Science and Technology (MHEST), Slovenia
• Institute of Health Carlos III (ISCIII), Spain
• Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey

The call will be conducted simultaneously by the funding organisations in their respective countries and coordinated centrally by the Joint Call Secretariat (JCS).

Aim of the Call

JTC 2011 aims at developing transnational innovative projects in oncology, clearly oriented towards a rapid application of new and more selective and effective tools and strategies for the prevention, diagnosis, early detection, and therapy of neoplastic diseases.

Transnational research proposals addressing the topic of the call must cover at least one of the following areas, which are equal in relevance for this call: prevention; early detection; diagnosis; prediction of response or resistance to treatment; prediction of treatment toxicity.

The research projects submitted within this call should fall into one of the following categories:

• bench to bed studies, stemming from previous laboratory and/or early phase clinical investigations;
• bed to bench studies, stemming from advanced clinical investigations.

In all cases, the research projects should clearly aim at the validation of previously identified candidate biomarkers or of their novel and/or combined use.

More information on the aims of the call can be found in the Call Text and in the Guidelines for Applicants on

• http://www.transcanfp7.eu/transcan/mod/resource/view.php?id=66)

Planned time schedule

• Publication of the JTC 2011: 14 December 2011
• Opening of electronic proposal submission system: 10 January 2012
• Deadline for electronic pre-proposals submission: 10 February 2012
• Communication of the pre-proposal evaluation results: 24 April 2012
• Deadline for electronic full proposals submission: 05 June 2012
• Communication of final evaluation result and funding decision: October 2012
• Start of funded research projects: March-April 2013